Norofert launches Brazilian fertilizer production line
Romanian agricultural biotechnology company Norofert has officially launched its new fertilizer production line in Chapecó, Brazil.
Romanian agricultural biotechnology company Norofert has officially launched its new fertilizer production line in Chapecó, Brazil.
Following the offer, Norofert issued 69,503 unsecured and non-convertible bonds having a nominal value of RON 100.
This growth was driven by the production and commercialization of agricultural inputs, including results from the USA operations.
The offering will include up to 150,000 nominative, dematerialized, unsecured, and non-convertible bonds, with a nominal value of RON 100 per bond.
Norofert has partnered with Engenutri Group, a top player in agribusiness, with over 25 years of experience in providing innovative solutions for nutrition and plant protection.
The collaboration with IFC supports Norofert in conducting comparative research to evaluate the impact of microbial inputs in soil on carbon emissions and CO2 sequestration.
Norofert announces the start of a production line for inputs and an investment of €250,000 in one of the most important agricultural area in the USA

Romania's real GDP growth is forecast to remain low over the next two years, primarily due to the necessary fiscal consolidation measures that will slow consumption.
CEC Bank continues to support entrepreneurs from rural and agricultural sectors by signing a new guarantee agreement with the Rural Credit Guarantee Fund (FGCR), which allows refinancing of AGRO and RURAL loans.
Endava, the technology-driven business transformation group, and Paysafe, a payments platform, announced a multi-year strategic partnership to bring payments and community engagement solutions to market faster.
Family business revenues are projected to reach $29 trillion by 2030, reflecting an 84% increase compared to 2020, according to a Deloitte study. These businesses currently account for 19% of all business revenue globally and represent more than 18,000 entities worldwide.
In 2023, the EU spent €1.72 trillion on healthcare expenditure, equivalent to 10.0% of the EU's gross domestic product, according to Eurostat.